[SRNE] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
21-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -183.19%
YoY- 49.07%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 121,910 4,665 4,874 4,019 2,243 902 988 2371.24%
PBT 94,953 -16,137 -25,499 -12,724 14,031 -46,113 -20,027 -
Tax 57,480 -1,398 -1,696 -701 -195 -1,164 -1,637 -
NP 33,959 -14,187 -23,064 -11,957 14,373 -44,949 -18,390 -
Tax Rate -60.54% - - - 1.39% - - -
Total Cost 87,951 18,852 27,938 15,976 -12,130 45,851 19,378 173.87%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 27.86 -304.12 -473.20 -297.51 640.79 -4,983.26 -1,861.34 -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS 0.44 -0.20 -0.45 -0.23 0.22 -0.97 -0.48 -
EPS Diluted 0.44 -0.20 -0.45 -0.23 0.22 -0.97 -0.48 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.